The 6th ELRIG Advances in Cell-based Screening 2026 is a free-to-attend, two-day scientific conference scheduled for May 6–7, 2026, in Gothenburg, Sweden.

Hosted at the AstraZeneca R&D site, this interactive event brings together biologists and chemists from academia and industry to explore the latest advancements in cell-based assays. The technical program focuses on state-of-the-art screening formats and best practices for target identification, target validation, and compound optimization.

While applicable across many therapeutic areas, the methodologies discussed – such as high-content imaging and complex 3D cellular models – are foundational to modern oncology drug discovery and precision medicine research.

Register.